세계의 세균성 질환 진단 시장(-2033년) : 유형별, 제품별, 기술별, 최종사용자별 규모, 예측, 지역별 전망, 경쟁 전략

Bacterial Disease Diagnostics Market Size- By Type, By Product, By Technology, By End User- Regional Outlook, Competitive Strategies and Segment Forecast to 2033

US $ 4,250 ￦ 5,978,000

Unprintable PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 불가능하며 인용 시에는 출처를 명시해 주시기 바랍니다

US $ 5,650 ￦ 7,947,000

PDF (Group License)

PDF 보고서를 동일 사업장에서 5명까지 이용할 수 있는 라이선스입니다. 인쇄는 5회까지 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다. 인용 시에는 출처를 명시해 주시기 바랍니다.

US $ 7,450 ￦ 10,479,000

PDF (Company License)

PDF 및 Excel 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다. 인용 시에는 출처를 명시해 주시기 바랍니다.

한글목차

세균성 질환 진단 시장 규모는 6.5%의 CAGR로 성장할 것으로 예상됩니다.

세균에는 여러 종류가 있습니다. 대부분은 몸에 좋은 세균이고 일부는 전염성이 있으며, 병원균은 감염을 유발하는 모든 세균을 말합니다. 항생제의 불필요한 사용을 방지하고 적절한 치료를 위해서는 세균 감염의 정확한 진단이 필수적입니다. 세균 감염을 확인하기 위해서는 염증이나 전신 기능 장애뿐만 아니라 세균의 존재도 관련되어 있기 때문에 일반적으로 여러 가지 진단 방법이 필요합니다.

또한, COVID-19의 원인이 된 신종 코로나바이러스는 각국 정부의 검사 절차의 신속화를 위한 지원을 불러일으켰습니다. COVID-19의 팬데믹으로 인해 일부 산업에서 수익이 감소했지만, COVID-19 검사에 대한 적용은 감염병 진단 시장을 돕고 규제 당국의 COVID-19 진단 제품 승인을 앞당기는 데 도움이 되었습니다.

세계의 세균성 질환 진단 시장을 조사했으며, 시장 개요, 시장 영향요인 및 시장 기회 분석, 시장 규모 추이 및 예측, 유형·제품·지역 등 각종 분류별 상세 분석, 경쟁 상황, 주요 기업 개요 등의 정보를 정리하여 전해드립니다.

목차

제1장 서론

제2장 조사 방법

제3장 주요 요약

제4장 시장 역학

• 성장 촉진요인, 억제요인, 기회·과제 분석
  • 성장 촉진요인
  • 성장 억제요인
  • 기회
  • 과제
• COVID-19에 의한 세계의 세균성 질환 진단 시장에 대한 영향

제5장 시장 변수와 전망

• SWOT 분석
• PESTEL 분석
• Porter's Five Forces 분석
• 히트맵 분석

제6장 경쟁 상황

• 제조 거점 분포·판매 지역·제품 유형
• M&A·제휴·제품 발매·협력

제7장 세계의 세균성 질환 진단 시장 : 유형별

• 시장 규모 점유율·예측
• 세균성 피부 감염증
• 식중독
• 성감염증

제8장 세계의 세균성 질환 진단 시장 : 제품별

• 시장 규모 점유율·예측
• 소모품
• 기기

제9장 세계의 세균성 질환 진단 시장 : 기술별

• 시장 규모 점유율·예측
• DNA 마이크로어레이
• 면역진단
• 등온 핵산 증폭 기술
• 중합효소 연쇄 반응

제10장 세계의 세균성 질환 진단 시장 : 최종사용자별

• 시장 규모 점유율·예측
• 병원
• 실험실
• 연구 센터

제11장 세계의 세균성 질환 진단 시장 예측

• 시장 규모·시장 점유율

제12장 세계의 세균성 질환 진단 시장 : 유형별

• 시장 규모·시장 점유율

제13장 세계의 세균성 질환 진단 시장 : 제품별

• 시장 규모·시장 점유율

제14장 세계의 세균성 질환 진단 시장 : 기술별

• 시장 규모·시장 점유율

제15장 세계의 세균성 질환 진단 시장 : 최종사용자별

• 시장 규모·시장 점유율

제16장 세계의 세균성 질환 진단 시장 : 지역별

• 시장 규모·시장 점유율
• 아시아태평양
• 유럽
• 중동 및 아프리카
• 북미
• 라틴아메리카

제17장 기업 개요

• Abbott Laboratories
• Accelerate Diagnostics Inc.
• Becton Dickinson and Co.
• Bio Rad Laboratories Inc.
• bioMerieux SA
• Bruker Corp.
• Danaher Corp
• DiaSorin SpA
• EKF Diagnostics Holdings Plc
• F. Hoffmann La Roche Ltd.
• GENERI BIOTECH s.r.o.
• Great Basin Scientific
• Hologic Inc.
• Meridian Bioscience Inc.
• Perkin Elmer Inc.
• QIAGEN NV
• Quest Diagnostics Inc.
• Siemens AG
• T2 Biosystems Inc.
• Takara Bio Inc.
• 기타

제18장 약어 리스트

제19장 레퍼런스 링크

제20장 결론

제21장 조사 범위

ksm

영문 목차

영문목차

Introduction and Overview

According to SPER Market Research, 'Bacterial Disease Diagnostics Market Size- By Type, By Product, By Technology, By End User- Regional Outlook, Competitive Strategies and Segment Forecast to 2033' state that the Bacterial Disease Diagnostics Market is predicted to reach with a CAGR of 6.5%.

The several forms of bacteria. However, the majority of them are good for the body while some of them are contagious. Pathogens include all bacteria that are responsible for infectious diseases. To prevent the needless use of antibiotics and to target the right therapy, an accurate diagnosis of bacterial infection is essential. In order to confirm a bacterial infection, more than one diagnostic method is typically needed because it involves the presence of germs as well as inflammation or systemic dysfunction.

Furthermore, the new coronavirus that causes COVID-19 has sparked support from governments all over the world for laboratories to expedite testing procedures. Although the pandemic reduced revenues in several industries, its application in COVID-19 testing helped the market for infectious illness diagnostics. The regulatory authorities hastened the licencing of COVID-19 diagnostic products.

Scope of the Report

Report Metric Details:

• Market size available for years: 2019-2033

• Base year considered: 2022

• Forecast period: 2023-2033

• Segments covered: By Type, By Product, By Technology, By End User

• Regions covered: North America, Asia-Pacific, Latin America, Middle East & Africa and Europe

• Companies Covered: Abbott Laboratories, Accelerate Diagnostics Inc., Becton Dickinson and Co., Bio Rad Laboratories Inc., bioMerieux SA, Bruker Corp., Danaher Corp., Meridian Bioscience Inc., Perkin Elmer Inc., Quest Diagnostics Inc., and Takara Bio Inc., Others

Market Segmentation:

• By Type: Based on the Type, Global Bacterial Disease Diagnostics Market is segmented as; Bacterial Skin Infections, Foodborne Infections, Sexually Transmitted Infections.

• By Product: Based on the Product, Global Bacterial Disease Diagnostics Market is segmented as; Consumables, Instruments.

• By End User: Based on the End User, Global Bacterial Disease Diagnostics Market is segmented as; Hospitals, Labs, Research Centres.

• By Region: This research also includes data for North America, Asia-Pacific, Latin America, Middle East & Africa and Europe.

Table of Contents

1. Introduction

• 1.1. Scope of the report
• 1.2. Market segment analysis

2. Research Methodology

• 2.1. Research data source
  • 2.1.1. Secondary Data
  • 2.1.2. Primary Data
  • 2.1.3. SPER's internal database
  • 2.1.4. Premium insight from KOL's
• 2.2. Market size estimation
  • 2.2.1. Top-down and Bottom-up approach
• 2.3. Data triangulation

3. Executive Summary

4. Market Dynamics

• 4.1. Driver, Restraint, Opportunity and Challenges analysis
  • 4.1.1. Drivers
  • 4.1.2. Restraints
  • 4.1.3. Opportunities
  • 4.1.4. Challenges
• 4.2. COVID-19 Impacts of the Global Bacterial Disease Diagnostics Market

5. Market variable and outlook

• 5.1. SWOT Analysis
  • 5.1.1. Strengths
  • 5.1.2. Weaknesses
  • 5.1.3. Opportunities
  • 5.1.4. Threats
• 5.2. PESTEL Analysis
  • 5.2.1. Political Landscape
  • 5.2.2. Economic Landscape
  • 5.2.3. Social Landscape
  • 5.2.4. Technological Landscape
  • 5.2.5. Environmental Landscape
  • 5.2.6. Legal Landscape
• 5.3. PORTER's Five Forces
  • 5.3.1. Bargaining power of suppliers
  • 5.3.2. Bargaining power of buyers
  • 5.3.3. Threat of Substitute
  • 5.3.4. Threat of new entrant
  • 5.3.5. Competitive rivalry
• 5.4. Heat Map Analysis

6. Competitive Landscape

• 6.1. Global Bacterial Disease Diagnostics Market Manufacturing Base Distribution, Sales Area, Product Type
• 6.2. Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in Global Bacterial Disease Diagnostics Market

7. Global Bacterial Disease Diagnostics Market, By Type (USD Million)

• 7.1. Global Bacterial Disease Diagnostics Market Value Share and Forecast, By Type, 2023-2033
• 7.2. Bacterial Skin Infections
• 7.3. Foodborne Infections
• 7.4. Sexually Transmitted Infections

8. Global Bacterial Disease Diagnostics Market, By Product (USD Million)

• 8.1. Global Bacterial Disease Diagnostics Market Value Share and Forecast, By Product, 2023-2033
• 8.2. Consumables
• 8.3. Instruments

9. Global Bacterial Disease Diagnostics Market, By Technology (USD Million)

• 9.1. Global Bacterial Disease Diagnostics Market Value Share and Forecast, By Technology, 2023-2033
• 9.2. DNA Microarray
• 9.3. Immunodiagnostics
• 9.4. Isothermal Nucleic Acid Amplification Technology
• 9.5. Polymerase Chain Reaction

10. Global Bacterial Disease Diagnostics Market, By End User (USD Million)

• 10.1. Global Bacterial Disease Diagnostics Market Value Share and Forecast, By End User, 2023-2033
• 10.2. Hospitals
• 10.3. Labs
• 10.4. Research Centres

11. Global Bacterial Disease Diagnostics Market Forecast, 2019-2033 (USD Million)

• 11.1. Global Bacterial Disease Diagnostics Market Size and Market Share

12. Global Bacterial Disease Diagnostics Market, By Type, 2019-2033 (USD Million)

• 12.1. Global Bacterial Disease Diagnostics Market Size and Market Share By Type (2019-2026)
• 12.2. Global Bacterial Disease Diagnostics Market Size and Market Share By Type (2027-2033)

13. Global Bacterial Disease Diagnostics Market, By Product, 2019-2033 (USD Million)

• 13.1. Global Bacterial Disease Diagnostics Market Size and Market Share By Product (2019-2026)
• 13.2. Global Bacterial Disease Diagnostics Market Size and Market Share By Product (2027-2033)

14. Global Bacterial Disease Diagnostics Market, By Technology, 2019-2033 (USD Million)

• 14.1. Global Bacterial Disease Diagnostics Market Size and Market Share By Technology (2019-2026)
• 14.2. Global Bacterial Disease Diagnostics Market Size and Market Share By Technology (2027-2033)

15. Global Bacterial Disease Diagnostics Market, By End User, 2019-2033 (USD Million)

• 15.1. Global Bacterial Disease Diagnostics Market Size and Market Share By End User (2019-2026)
• 15.2. Global Bacterial Disease Diagnostics Market Size and Market Share By End User (2027-2033)

16. Global Bacterial Disease Diagnostics Market, By Region, 2019-2033 (USD Million)

• 16.1. Global Bacterial Disease Diagnostics Market Size and Market Share By Region (2019-2026)
• 16.2. Global Bacterial Disease Diagnostics Market Size and Market Share By Region (2027-2033)
• 16.3. Asia-Pacific
  • 16.3.1. Australia
  • 16.3.2. China
  • 16.3.3. India
  • 16.3.4. Japan
  • 16.3.5. South Korea
  • 16.3.6. Rest of Asia-Pacific
• 16.4. Europe
  • 16.4.1. France
  • 16.4.2. Germany
  • 16.4.3. Italy
  • 16.4.4. Spain
  • 16.4.5. United Kingdom
  • 16.4.6. Rest of Europe
• 16.5. Middle East and Africa
  • 16.5.1. Kingdom of Saudi Arabia
  • 16.5.2. United Arab Emirates
  • 16.5.3. Rest of Middle East & Africa
• 16.6. North America
  • 16.6.1. Canada
  • 16.6.2. Mexico
  • 16.6.3. United States
• 16.7. Latin America
  • 16.7.1. Argentina
  • 16.7.2. Brazil
  • 16.7.3. Rest of Latin America

17. Company Profile

• 17.1. Abbott Laboratories
  • 17.1.1. Company details
  • 17.1.2. Financial outlook
  • 17.1.3. Product summary
  • 17.1.4. Recent developments
• 17.2. Accelerate Diagnostics Inc.
  • 17.2.1. Company details
  • 17.2.2. Financial outlook
  • 17.2.3. Product summary
  • 17.2.4. Recent developments
• 17.3. Becton Dickinson and Co.
  • 17.3.1. Company details
  • 17.3.2. Financial outlook
  • 17.3.3. Product summary
  • 17.3.4. Recent developments
• 17.4. Bio Rad Laboratories Inc.
  • 17.4.1. Company details
  • 17.4.2. Financial outlook
  • 17.4.3. Product summary
  • 17.4.4. Recent developments
• 17.5. bioMerieux SA
  • 17.5.1. Company details
  • 17.5.2. Financial outlook
  • 17.5.3. Product summary
  • 17.5.4. Recent developments
• 17.6. Bruker Corp.
  • 17.6.1. Company details
  • 17.6.2. Financial outlook
  • 17.6.3. Product summary
  • 17.6.4. Recent developments
• 17.7. Danaher Corp
  • 17.7.1. Company details
  • 17.7.2. Financial outlook
  • 17.7.3. Product summary
  • 17.7.4. Recent developments
• 17.8. DiaSorin SpA
  • 17.8.1. Company details
  • 17.8.2. Financial outlook
  • 17.8.3. Product summary
  • 17.8.4. Recent developments
• 17.9. EKF Diagnostics Holdings Plc
  • 17.9.1. Company details
  • 17.9.2. Financial outlook
  • 17.9.3. Product summary
  • 17.9.4. Recent developments
• 17.10. F. Hoffmann La Roche Ltd.
  • 17.10.1. Company details
  • 17.10.2. Financial outlook
  • 17.10.3. Product summary
  • 17.10.4. Recent developments
• 17.11. GENERI BIOTECH s.r.o.
  • 17.11.1. Company details
  • 17.11.2. Financial outlook
  • 17.11.3. Product summary
  • 17.11.4. Recent developments
• 17.12. Great Basin Scientific
  • 17.12.1. Company details
  • 17.12.2. Financial outlook
  • 17.12.3. Product summary
  • 17.12.4. Recent developments
• 17.13. Hologic Inc.
  • 17.13.1. Company details
  • 17.13.2. Financial outlook
  • 17.13.3. Product summary
  • 17.13.4. Recent developments
• 17.14. Meridian Bioscience Inc.
  • 17.14.1. Company details
  • 17.14.2. Financial outlook
  • 17.14.3. Product summary
  • 17.14.4. Recent developments
• 17.15. Perkin Elmer Inc.
  • 17.15.1. Company details
  • 17.15.2. Financial outlook
  • 17.15.3. Product summary
  • 17.15.4. Recent developments
• 17.16. QIAGEN NV
  • 17.16.1. Company details
  • 17.16.2. Financial outlook
  • 17.16.3. Product summary
  • 17.16.4. Recent developments
• 17.17. Quest Diagnostics Inc.
  • 17.17.1. Company details
  • 17.17.2. Financial outlook
  • 17.17.3. Product summary
  • 17.17.4. Recent developments
• 17.18. Siemens AG
  • 17.18.1. Company details
  • 17.18.2. Financial outlook
  • 17.18.3. Product summary
  • 17.18.4. Recent developments
• 17.19. T2 Biosystems Inc.
  • 17.19.1. Company details
  • 17.19.2. Financial outlook
  • 17.19.3. Product summary
  • 17.19.4. Recent developments
• 17.20. Takara Bio Inc.
  • 17.20.1. Company details
  • 17.20.2. Financial outlook
  • 17.20.3. Product summary
  • 17.20.4. Recent developments
• 17.21. Others

18. List of Abbreviations

19. Reference Links

20. Conclusion

21. Research Scope

관련자료